No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
773 |
4. Check minimum number of eventsNone |
773 |
5. Include endpointsNone |
773 |
6. Filter based on genotype QC (FinnGen only) |
773 |
Control definitions (FinnGen only)
- Control exclude
- AB1_MYCOSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Other superficial mycoses
based on the number of shared cases.
Similar with more cases:
- Mycoses
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5932 | 2806 | 3076 |
| Only index persons | 5363 | 2569 | 2794 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.09 |
| Only index persons | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 38.43 | 39.96 | 37.05 |
| Only index persons | 37.82 | 39.40 | 36.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 773 | 397 | 376 |
| Unadjusted period prevalence (%) | 0.15 | 0.14 | 0.17 |
| Median age at first event (years) | 44.35 | 42.29 | 46.53 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 676
- Matched controls
- 6762
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B36.0
ICD-10 Finland
Pityriasis versicolor
1025.9
323.0
500
18
J02AB02
ATC
ketoconazole; oral
11.5
34.2
65
62
B36.8
ICD-10 Finland
Other specified superficial mycoses
94.9
33.1
36
*
J02AC02
ATC
itraconazole; systemic
3.5
32.9
185
664
B36.9
ICD-10 Finland
Superficial mycosis, unspecified
92.2
32.0
35
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.0
30.4
105
241
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
26.0
166
639
H62.2*B36.9
ICD-10 Finland
Otomycosis NOS
+∞
25.2
24
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.7
22.5
187
844
11100
ICD-8 Finland
Dermatomycosis, other and unspecified, Pityriasis versicolor
+∞
20.9
20
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.6
18.4
88
270
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
17.7
95
319
D01AC02
ATC
miconazole; topical
3.7
15.8
71
207
XQ848
NOMESCO Finland
Dermatological photography
6.1
14.7
40
69
E0000UV
ATC
NA
2.0
14.7
276
1758
11199
ICD-8 Finland
Dermatomycosis, other and unspecified, Unspecified
+∞
14.6
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
14.0
263
1663
B36
ICD-10 Finland
Other superficial mycoses
26.3
13.4
18
7
127
Kela drug reimbursment
Transplant complication
9.6
13.1
26
28
B35.3
ICD-10 Finland
Tinea pedis
5.3
12.9
39
77
1110A
ICD-9 Finland
Dermatomycosis, other and unspecified, Pityriasis versicolor
+∞
12.5
12
*
A07EC01
ATC
sulfasalazine; oral, rectal
3.1
12.4
70
242
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.7
12.3
41
91
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.2
12.2
37
74
D07AC01
ATC
betamethasone; topical
1.9
11.7
223
1401
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.5
11.6
23
25
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.6
11.4
52
154
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.1
11.3
35
72
Z94.0
ICD-10 Finland
Kidney transplant status
14.2
11.0
18
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
10.7
165
953
L04AA01
ATC
[U] ciclosporin; systemic
7.7
10.7
24
32
L04AX01
ATC
azathioprine; systemic
3.6
10.4
46
133
L04AA06
ATC
mycophenolic acid; systemic
7.3
10.3
24
34
J02AC01
ATC
fluconazole; systemic
1.8
10.3
253
1713
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
10.2
126
667
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
10.2
10.1
19
19
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
9.6
61
230
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
9.3
9.6
19
21
L04AD01
ATC
ciclosporin; systemic
6.3
9.5
24
39
H02AB06
ATC
prednisolone; systemic
1.7
9.4
282
2010
D01AC03
ATC
econazole; topical
3.2
9.1
47
154
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
9.1
170
1047
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
9.0
64
259
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.9
259
1824
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.9
8.9
55
201
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
8.9
51
180
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
14.3
8.7
14
10
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.5
8.6
39
116
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.5
8.5
38
112
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
8.5
87
421
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
8.4
72
322
TK800
NOMESCO Finland
Hemodialysis
6.3
8.4
21
34
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
8.1
36
106
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.7
7.9
19
29
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
7.9
128
747
H60.3
ICD-10 Finland
Other infective otitis externa
5.0
7.6
23
47
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.6
7.6
52
206
A02BC01
ATC
omeprazole; systemic
1.8
7.5
154
970
L30.0
ICD-10 Finland
Nummular dermatitis
3.9
7.4
29
77
D01BA02
ATC
terbinafine; oral; topical
1.8
7.4
154
972
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.4
223
1568
L04AB04
ATC
adalimumab; parenteral
4.8
7.4
23
49
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.3
230
1632
J01DB01
ATC
cefalexin; oral
1.7
7.3
537
4706
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.3
125
740
11180
ICD-8 Finland
Dermatomycosis, other and unspecified, Erythrasma mycoides
+∞
7.3
7
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.2
264
1947
L17
ICPC
Foot/toe symptom/complaint
1.7
7.2
149
940
C08CA02
ATC
felodipine; oral
2.7
6.9
46
180
B03XA02
ATC
darbepoetin alfa; parenteral
7.6
6.9
15
20
R03BB04
ATC
tiotropium bromide; inhalant
2.4
6.9
57
249
P01BA02
ATC
hydroxychloroquine; oral
2.5
6.9
54
229
N02BE01
ATC
paracetamol; systemic, rectal
1.7
6.9
535
4708
A02BC02
ATC
pantoprazole; systemic
1.5
6.9
381
3087
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
6.9
210
1477
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
6.9
59
262
UJF32
NOMESCO Finland
Coloscopy
1.8
6.8
137
852
L30.3
ICD-10 Finland
Infective dermatitis
3.8
6.8
27
73
A06AD11
ATC
lactulose; oral
2.2
6.8
67
321
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.7
164
1083
R50.9
ICD-10 Finland
Fever, unspecified
2.0
6.7
91
498
D07AC13
ATC
mometasone; topical
1.6
6.7
179
1214
H02AB04
ATC
methylprednisolone; systemic
1.9
6.7
94
518
S18
ICPC
Laceration/cut
1.6
6.6
234
1705
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
6.6
53
231
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
6.5
46
186
B35.4
ICD-10 Finland
Tinea corporis
6.3
6.5
16
26
N05CF01
ATC
zopiclone; oral
1.6
6.5
169
1138
B35.1
ICD-10 Finland
Tinea unguium
2.9
6.5
38
138
ZXA00
NOMESCO Finland
Right side
1.7
6.3
143
921
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.2
6.3
11
10
R51.80
ICD-10 Finland
Headache
1.8
6.3
100
580
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
6.2
56
259
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
6.1
50
220
SPAT1263
SPAT
Sampling
1.5
6.0
259
1961
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
432
3005
1.99
19.25
10.9
6.0
28.7
28.6
%
0.06
413
2827
427
2961
1.99
19.17
10.5
5.8
57.1
56.7
%
0.27
407
2797
486
3538
2.01
18.81
14.7
9.1
4.1
4.0
e9/l
0.44
437
3104
162
842
2.17
15.65
2.7
1.8
—
—
—
0
0
578
4620
2.00
15.34
11.3
7.3
74.7
76.3
u/l
0.42
557
4359
31
64
5.00
14.37
1.4
1.3
—
—
—
0
0
337
2309
1.81
14.27
6.9
4.9
36.0
36.4
g/l
0.56
314
2179
94
410
2.47
13.59
1.4
1.3
173.1
170.6
u/ml
0.02
88
375
341
2410
1.74
12.51
8.7
6.1
1.2
1.2
mmol/l
0.03
313
2219
370
2685
1.73
12.27
10.2
6.8
1.2
1.2
mmol/l
0.01
324
2294
443
3395
1.71
11.89
6.6
4.7
6.7
6.6
mmol/l
0.36
419
3133
403
3021
1.70
11.64
8.0
6.3
10.7
11.0
umol/l
0.46
383
2872
334
2382
1.71
11.61
2.9
2.2
73.7
74.2
nmol/l
0.14
311
2174
293
2026
1.72
11.34
4.5
2.9
—
—
—
0
0
547
4496
1.74
10.86
7.4
3.8
11.6
10.2
mm/h
1.53
524
4188
43
140
3.19
10.75
10.5
6.1
178.3
404.2
iu/ml
—
6
20
154
892
1.91
10.71
5.7
3.4
0.8
0.8
mmol/l
0.25
148
850
27
65
4.27
10.42
1.8
1.7
—
—
—
0
0
265
1818
1.70
10.36
4.0
2.6
54.4
55.6
u/l
0.30
243
1703
483
3878
1.65
10.08
5.7
3.8
89.8
354.7
e6/l
—
5
54
241
1636
1.69
9.68
3.4
2.0
152.3
285.3
u/l
1.48
229
1553
80
379
2.24
9.54
2.4
1.6
—
—
—
0
0
293
2135
1.60
8.69
4.4
3.4
31.3
32.2
u/l
0.21
278
2043
105
572
1.97
8.67
2.3
2.0
390.2
373.6
nmol/l
0.17
88
537
251
1774
1.61
8.39
3.8
3.2
7.6
8.4
mmol/l
1.78
210
1510
23
58
4.06
8.38
1.9
1.8
—
—
—
0
0
553
4716
1.61
7.95
4.4
3.8
14.6
14.5
pmol/l
0.07
505
4340
26
75
3.55
7.88
3.3
1.5
—
—
—
0
0
103
578
1.90
7.77
2.5
1.8
—
—
—
0
0
95
520
1.94
7.72
2.4
2.5
0.2
0.2
g/l
0.68
85
491
51
218
2.43
7.70
2.0
1.5
3.4
0.0
iu/ml
0.97
11
37
73
364
2.11
7.67
4.1
3.0
183.9
175.8
ng/l
0.08
63
321
216
1501
1.61
7.63
3.5
2.5
1028.5
5961.4
umol/l
3.23
195
1336
26
77
3.46
7.58
4.5
3.3
1.5
1.3
%
0.19
21
64
50
217
2.39
7.31
3.0
1.8
—
—
—
0
0
136
849
1.73
7.22
3.4
2.3
12.1
14.0
umol/l
2.36
131
798
194
1331
1.61
7.16
3.7
3.0
1359.2
1005.2
ng/l
0.68
172
1105
218
1540
1.58
7.11
3.9
2.8
0.4
0.4
e6/l
0.10
169
1127
119
718
1.78
7.10
3.6
2.4
22.7
24.3
%
0.53
97
628
640
5714
1.70
7.10
5.2
4.4
1.8
2.0
mu/l
0.42
592
5319
377
3000
1.50
7.08
5.8
4.3
0.0
0.0
estimate
0.50
79
565
158
1035
1.66
7.00
4.5
3.5
103.0
648.3
ng/l
2.66
107
734
278
2083
1.52
6.92
4.1
3.2
56.7
40.1
ng/l
0.34
170
1259
379
3028
1.49
6.92
4.6
3.1
0.0
0.0
estimate
0.50
75
542
59
283
2.17
6.85
2.6
2.2
36.1
38.0
u/l
0.38
52
255
47
205
2.38
6.81
2.8
1.7
—
—
—
0
0
99
573
1.83
6.77
2.5
1.7
—
—
—
0
0
548
4735
1.54
6.77
3.5
3.4
—
—
—
0
0
101
590
1.82
6.71
6.4
8.7
1.0
0.9
mmol/l
0.01
85
473
35
134
2.69
6.64
3.3
1.6
—
—
—
0
0
196
1370
1.58
6.63
1.9
1.7
0.8
1.0
mg/l
1.31
137
1010
84
465
1.90
6.60
5.9
3.7
2.3
1.9
mmol/l
0.56
67
372
372
2983
1.48
6.54
4.5
3.1
0.0
0.0
estimate
0.00
78
546
124
778
1.71
6.43
3.5
2.3
2.3
2.4
g/l
0.27
119
732
19
51
3.79
6.39
2.6
3.3
63.0
55.0
%
0.71
12
39
350
2783
1.47
6.37
3.4
2.7
111.2
110.2
ug/l
0.03
331
2610
243
1796
1.51
6.35
3.8
3.3
2.3
2.4
mmol/l
0.43
215
1613
27
93
2.97
6.21
3.6
1.6
—
—
—
0
0
101
604
1.77
6.20
14.7
17.8
1.2
1.3
inr
0.20
23
88
71
381
1.95
6.12
2.2
3.1
66.9
67.3
g/l
0.22
66
357
18
48
3.82
6.11
1.9
1.2
9851.7
5920.0
e6/l
0.32
13
32
222
1624
1.51
6.04
4.5
4.1
10.3
9.5
mg/mmol
0.10
146
1049
71
384
1.93
5.98
6.3
4.1
122.3
81.8
ng/l
1.11
64
350
689
6349
1.78
5.94
22.5
11.9
18.7
22.2
mg/l
2.88
571
4925
74
407
1.90
5.93
2.4
2.3
5.4
8.4
ug/l
1.07
66
367
156
1061
1.59
5.87
1.4
1.3
31.6
30.3
iu/ml
0.05
58
334
40
174
2.37
5.86
3.8
2.8
—
—
—
0
0
140
928
1.62
5.86
3.0
2.5
0.7
1.1
e6/l
1.26
78
500
83
481
1.81
5.66
1.3
1.2
108.4
154.0
iu/ml
0.61
29
196
23
77
3.05
5.57
3.5
1.5
—
—
—
0
0
112
711
1.67
5.54
2.9
2.7
6.3
8.3
umol/l
0.96
90
625
33
135
2.51
5.52
3.4
1.6
—
—
—
0
0
213
1572
1.49
5.48
5.4
3.4
0.0
0.0
estimate
1.08
79
551
61
324
1.96
5.43
5.4
3.2
2.0
1.8
mmol/l
0.15
38
229
684
6322
1.71
5.40
22.1
13.1
139.4
139.7
mmol/l
1.43
673
6161
63
339
1.93
5.40
5.4
3.2
5.2
5.1
kpa
0.37
55
318
686
6349
1.72
5.35
22.2
13.2
4.0
4.0
mmol/l
2.04
671
6177
274
2141
1.43
5.20
2.0
1.9
94.7
94.8
pmol/l
0.01
148
1163
25
93
2.74
5.05
2.5
1.5
—
—
—
0
0
186
1356
1.49
5.04
2.5
2.1
3.0
2.9
mg/l
0.12
163
1165
44
213
2.13
5.04
2.7
1.6
—
—
—
0
0
67
377
1.85
5.03
2.5
3.6
4.4
4.6
pmol/l
1.50
55
340
202
1503
1.47
4.93
1.3
1.2
2.4
1.6
u/ml
0.20
47
419
27
106
2.60
4.93
3.4
1.5
—
—
—
0
0
54
289
1.93
4.73
1.9
1.6
—
—
—
0
0
147
1037
1.52
4.64
1.3
1.3
22.7
9.3
u/ml
0.91
52
420
291
2336
1.39
4.61
4.8
3.2
—
—
—
0
0
37
174
2.18
4.57
1.9
2.4
2.7
3.1
g/l
1.44
29
142
38
184
2.12
4.38
1.9
2.3
3.7
3.8
g/l
0.19
29
139
38
184
2.12
4.38
1.9
2.3
—
—
—
0
0
38
184
2.12
4.38
1.9
2.3
7.1
7.3
g/l
0.40
30
147
24
95
2.58
4.33
1.1
1.4
—
—
—
0
0
24
95
2.58
4.33
1.1
1.4
—
—
—
0
0
8
9
8.97
4.28
5.2
4.9
—
—
—
0
0
21
78
2.74
4.28
2.7
1.5
—
—
—
0
0
643
5932
1.50
4.26
17.2
10.6
87.9
87.8
ml/min/173m2
0.04
554
4831
127
886
1.52
4.21
2.9
2.7
4.1
2.1
e6/l
1.04
66
464
20
73
2.79
4.21
1.1
1.1
—
—
—
0
0
20
73
2.79
4.21
1.1
1.1
—
—
—
0
0
178
1329
1.44
4.20
5.3
3.4
1.0
1.0
kg/l
1.25
21
183
164
1208
1.45
4.15
1.6
1.5
19.3
20.4
nmol/l
0.44
142
1055
17
57
3.03
4.14
3.2
3.6
—
—
—
0
0
35
169
2.12
4.08
1.9
2.4
10.2
10.7
g/l
0.19
30
151
15
47
3.23
4.07
1.6
1.3
0.6
0.3
u/ml
—
7
22
37
183
2.07
4.05
1.3
1.2
—
1.1
—
0
6
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
143
2.22
4.04
1.9
2.5
0.2
0.4
u/ml
2.07
16
71
16
53
3.06
3.98
2.4
1.2
—
—
—
0
0
716
6792
1.73
3.96
15.7
9.4
28.3
28.1
u/l
0.08
706
6600
28
125
2.29
3.94
3.8
2.2
24.5
24.3
mmol/l
0.07
21
112
35
172
2.08
3.91
1.3
1.2
2.4
6.2
u/ml
—
5
26
30
139
2.21
3.88
1.8
1.3
—
—
—
0
0
16
54
3.00
3.86
1.0
1.1
—
—
—
0
0
16
54
3.00
3.86
2.4
1.2
—
—
—
0
0
16
54
3.00
3.86
1.0
1.1
—
—
—
0
0
150
1101
1.45
3.86
1.7
1.6
189394348.3
20671983.3
pmol/l
0.87
132
953
187
1433
1.40
3.78
2.4
2.1
—
—
—
0
0
7
8
8.82
3.78
4.9
1.8
—
—
—
0
0
610
5608
1.42
3.78
6.4
5.1
39.8
39.1
mmol/mol
1.07
576
5284
16
55
2.95
3.75
1.0
1.1
—
—
—
0
0
16
55
2.95
3.75
1.0
1.1
—
—
—
0
0
16
55
2.95
3.75
1.0
1.1
—
—
—
0
0
56
329
1.76
3.70
2.9
2.2
9666.1
3802.9
u/l
0.40
19
134
9
16
5.68
3.66
4.2
4.6
—
—
—
0
0
41
220
1.91
3.61
2.8
1.9
2.9
2.1
ug/l
0.19
36
204
17
62
2.78
3.60
1.0
1.1
—
—
—
0
0
27
125
2.20
3.51
3.2
4.0
30.0
36.5
umol/l
1.13
22
107
24
106
2.30
3.48
3.5
2.4
127.8
132.9
g/l
0.40
16
76
29
139
2.13
3.47
1.5
1.3
—
—
—
0
0
26
120
2.21
3.42
6.0
3.9
60.8
56.5
%
1.16
26
120
38
203
1.92
3.40
2.8
2.2
—
—
—
0
0
23
102
2.29
3.32
1.5
1.5
—
—
—
0
0
12
38
3.19
3.22
3.0
2.9
—
—
—
0
0
25
118
2.16
3.13
4.7
3.5
4.3
4.2
e9/l
0.18
25
118
183
1444
1.35
3.04
1.7
1.6
—
—
—
0
0
13
45
2.92
3.03
1.2
1.0
—
—
—
0
0
12
40
3.03
2.98
2.7
2.8
11.2
13.9
%
—
5
20
15
57
2.66
2.98
4.5
1.6
—
—
—
0
0
747
7238
1.95
2.93
30.8
17.6
137.2
138.1
g/l
0.91
739
7158
14
52
2.72
2.90
2.3
1.7
—
—
—
0
0
14
52
2.72
2.90
2.3
1.7
—
—
—
0
0
14
52
2.72
2.90
2.3
1.7
—
—
—
0
0
29
151
1.96
2.83
1.5
1.2
325.9
219.6
u/ml
0.76
21
93
54
340
1.63
2.82
1.5
1.4
—
—
—
0
0
27
138
1.99
2.78
1.2
1.1
0.5
2.2
u/ml
—
10
54
116
862
1.41
2.78
1.8
1.6
1233.4
1152.0
nmol/l
0.35
88
682
501
4562
1.28
2.70
4.2
3.0
55.3
44.2
u/l
1.50
481
4330
35
199
1.79
2.64
1.6
1.3
—
—
—
0
0
38
222
1.75
2.62
6.3
3.7
24.5
25.1
mmol/l
0.50
32
213
11
38
2.92
2.59
1.3
1.1
1.0
1.1
u/l
—
6
19
26
135
1.96
2.58
2.1
1.5
87.9
105.6
u/ml
0.50
11
29
5
7
7.18
2.55
15.0
5.1
4.3
7.5
mmol/l
—
5
7
21
101
2.11
2.55
1.1
1.1
—
—
—
0
0
29
159
1.86
2.47
1.4
1.2
—
—
—
0
0
14
57
2.48
2.46
1.1
1.2
—
—
—
0
0
56
370
1.55
2.43
1.6
1.4
24.9
22.5
iu/l
0.24
46
313
22
111
2.01
2.37
4.0
1.5
—
—
—
0
0
8
22
3.66
2.37
4.1
2.1
55.9
102.2
ug/l
—
8
22
12
46
2.63
2.36
1.8
3.0
—
—
—
0
0
17
78
2.21
2.32
1.9
1.5
—
—
—
0
0
328
2876
1.24
2.32
4.7
3.9
—
—
—
0
0
18
85
2.14
2.30
1.2
1.3
—
—
—
0
0
8
23
3.50
2.27
4.6
1.3
—
—
—
0
0
17
79
2.18
2.26
1.9
1.5
—
—
—
0
0
17
79
2.18
2.26
1.9
1.5
—
—
—
0
0
667
6363
1.35
2.20
5.0
4.4
2.7
2.8
mmol/l
1.83
632
5969
634
6005
1.31
2.20
4.6
4.0
5.9
5.9
mmol/l
0.59
584
5569
8
24
3.36
2.18
2.3
1.1
—
—
—
0
0
88
652
1.39
2.17
8.0
6.0
—
—
—
0
0
9
30
3.02
2.15
1.0
1.4
—
—
—
0
0
9
30
3.02
2.15
1.0
1.4
—
—
—
0
0
9
31
2.92
2.07
1.0
1.1
2075.6
1616.5
miu/ml
—
9
31
7
20
3.52
2.06
2.4
1.1
—
—
—
0
0
22
118
1.89
2.03
1.3
1.1
—
—
—
0
0
9
32
2.83
2.00
1.4
1.8
—
1224630.0
iu/ml
—
0
5
13
57
2.30
1.98
2.0
2.2
729.8
723.1
e6/l
—
6
22
24
134
1.82
1.97
1.9
4.5
80.4
32.3
mg/l
0.58
19
115
24
134
1.82
1.97
1.9
4.5
48.9
96.8
mg/l
0.52
18
114
76
561
1.39
1.93
3.5
2.4
35.6
122.5
u/l
0.52
67
486
16
78
2.07
1.92
1.9
1.6
—
—
—
0
0
16
79
2.05
1.86
1.9
1.5
—
—
—
0
0
16
79
2.05
1.86
1.9
1.5
—
—
—
0
0
11
46
2.41
1.86
1.1
1.0
—
—
—
0
0
25
145
1.75
1.83
2.9
2.4
23.0
103.7
ug/min
1.52
15
84
32
199
1.63
1.83
1.3
1.1
—
—
—
0
0
9
35
2.59
1.80
3.2
2.7
488.0
715.1
u/ml
—
9
35
115
915
1.30
1.80
2.8
2.8
2.4
2.4
mmol/l
0.25
97
808
11
47
2.36
1.78
1.6
1.5
—
—
—
0
0
62
449
1.41
1.77
3.9
2.5
71.1
73.8
ml/min/173m2
0.16
25
181
33
209
1.60
1.76
1.9
2.0
96.9
91.0
%
0.97
33
191
656
6291
1.28
1.71
4.6
4.0
4.6
4.7
mmol/l
3.28
629
5938
11
48
2.31
1.71
1.3
1.4
—
—
—
0
0
7
25
2.82
1.65
1.3
1.8
—
—
—
0
0
38
254
1.52
1.63
1.4
1.4
—
—
—
0
0
29
183
1.61
1.59
1.2
1.1
—
—
—
0
0
6
20
3.01
1.58
2.7
1.3
—
—
—
0
0
72
547
1.35
1.57
5.0
2.9
—
—
—
0
0
17
92
1.87
1.57
3.1
2.8
4.2
6.1
u/ml
0.48
17
84
12
57
2.12
1.55
1.2
1.5
0.9
1.0
g/l
0.74
12
57
8
33
2.44
1.54
1.0
1.1
187.0
162.4
iu/ml
—
8
33
29
185
1.59
1.53
1.2
1.1
—
—
—
0
0
21
123
1.73
1.52
4.2
3.9
14.2
24.7
mg/l
1.66
11
77
7
27
2.61
1.51
1.4
1.6
1.1
9.1
nmol/l
—
7
22
6
22
2.74
1.43
1.0
2.5
226.5
190.4
u/l
—
6
22
12
60
2.02
1.38
1.8
1.2
—
—
—
0
0
6
23
2.62
1.37
1.7
2.1
—
—
—
0
0
5
17
2.95
1.36
1.2
1.3
—
—
—
0
0
29
192
1.53
1.34
2.0
2.2
170.1
172.7
%
0.05
29
183
32
217
1.50
1.32
1.7
1.5
—
—
—
0
0
36
251
1.46
1.31
5.2
2.8
0.6
0.7
%
1.01
36
245
71
555
1.31
1.30
2.3
2.2
13.9
13.7
nmol/l
0.07
64
511
24
153
1.59
1.30
1.5
1.5
279.5
298.3
ug/g
0.17
14
96
220
1947
1.18
1.29
4.5
4.2
1.9
2.1
ug/l
0.22
201
1770
13
69
1.90
1.29
1.5
1.2
—
—
—
0
0
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
649
6264
1.22
1.28
4.5
4.0
1.4
1.4
mmol/l
1.26
617
5892
10
48
2.10
1.28
5.0
1.7
—
—
—
0
0
19
115
1.67
1.25
1.0
1.1
78.7
66.0
iu/ml
—
7
29
23
147
1.58
1.24
1.8
1.6
—
—
—
0
0
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
5
19
2.64
1.21
1.2
1.3
—
—
—
0
0
5
19
2.64
1.21
1.2
1.3
—
—
—
0
0
51
385
1.35
1.20
1.6
1.3
—
—
—
0
0
635
6128
1.20
1.18
20.4
12.7
41.1
40.6
%
1.12
481
4836
22
141
1.58
1.18
1.9
1.5
—
—
—
0
0
16
96
1.68
1.11
3.4
2.3
6.9
5.1
umol/l
0.34
11
69
184
1627
1.17
1.09
1.7
1.7
1.4
1.4
mmol/l
0.16
156
1406
52
402
1.31
1.06
6.6
3.5
1.2
1.2
mmol/l
0.15
42
353
21
137
1.55
1.06
1.2
1.6
188.5
1394.0
e6/l
0.69
15
113
21
137
1.55
1.06
1.1
1.5
2.9
11.6
e6/l
0.99
14
110
5
22
2.28
1.03
1.0
1.3
74.8
123.9
nmol/l
—
5
15
9
47
1.93
1.02
1.6
1.5
—
—
—
0
0
9
47
1.93
1.02
1.8
1.4
—
—
—
0
0
625
6045
1.18
1.02
4.2
3.6
1.4
1.3
mmol/l
1.42
590
5675
26
180
1.46
1.02
4.6
4.2
1.3
1.3
mmol/l
0.01
26
174
40
300
1.35
1.01
4.3
2.7
0.6
0.1
e6/l
0.73
40
292
5
23
2.18
0.98
1.0
1.0
110.3
26.8
u/ml
—
5
23
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
18
116
1.56
0.97
1.6
1.8
—
—
—
0
0
7
36
1.95
0.97
1.0
1.2
—
—
—
0
0
61
490
1.27
0.96
3.2
4.4
2.8
21.1
ug/l
1.13
46
403
33
243
1.37
0.94
1.5
1.4
9.4
9.0
u/l
0.05
24
200
7
37
1.90
0.94
4.4
1.5
—
—
—
0
0
17
109
1.57
0.94
1.2
1.0
0.8
1.8
u/ml
—
7
51
16
243
0.65
0.91
1.3
1.4
—
—
—
0
0
6
28
2.15
0.91
2.2
1.4
10.2
16.0
u/l
—
6
28
16
242
0.65
0.90
1.2
1.4
—
—
—
0
0
16
242
0.65
0.90
1.2
1.4
—
—
—
0
0
16
242
0.65
0.90
1.3
1.4
—
—
—
0
0
15
95
1.59
0.88
4.3
2.1
15.7
16.9
%
—
9
42
8
43
1.87
0.87
2.3
1.9
—
—
—
0
0
6
30
2.01
0.87
1.2
1.4
—
26.6
—
0
5
11
65
1.70
0.82
1.5
1.4
9.4
12.6
mmol/l
—
6
15
18
260
0.68
0.82
1.3
1.5
—
—
—
0
0
40
313
1.29
0.79
1.9
1.6
317.4
304.9
mu/l
0.08
32
287
569
5500
1.13
0.79
24.6
14.5
13.6
13.5
%
1.01
562
5389
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
8
48
1.67
0.79
2.8
2.8
—
—
—
0
0
172
1552
1.14
0.78
4.3
3.7
21.6
21.3
%
0.07
66
662
24
176
1.38
0.73
1.6
1.9
4.4
5.6
iu/l
—
6
57
5
25
2.01
0.72
1.0
2.1
—
74.2
%
—
0
6
6
109
0.55
0.72
1.3
1.2
—
—
—
0
0
72
615
1.19
0.68
1.9
2.0
—
—
—
0
0
10
62
1.62
0.65
3.0
1.6
—
—
—
0
0
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
15
106
1.42
0.58
4.5
5.8
340.1
363.0
umol/l
0.22
15
95
78
682
1.16
0.57
4.2
4.1
30.3
31.0
%
0.24
60
482
6
35
1.72
0.57
1.2
1.1
—
—
—
0
0
29
229
1.28
0.57
1.3
1.4
—
—
—
0
0
125
1130
1.13
0.57
2.2
2.1
—
—
—
0
0
117
1056
1.13
0.55
1.7
1.5
—
—
—
0
0
26
204
1.28
0.54
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
9
63
1.43
0.52
1.0
1.0
—
—
—
0
0
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
56
486
1.16
0.47
1.9
1.9
—
—
—
0
0
14
103
1.37
0.45
1.2
1.1
—
—
—
0
0
24
297
0.80
0.45
1.7
1.4
—
—
—
0
0
18
140
1.29
0.42
1.2
1.2
—
—
—
0
0
5
33
1.52
0.41
5.8
1.5
—
—
—
0
0
65
728
0.88
0.41
1.5
1.7
—
—
—
0
0
16
123
1.31
0.40
1.0
1.5
0.5
0.4
nmol/l
0.46
11
102
112
1030
1.10
0.40
2.2
2.0
—
—
—
0
0
21
170
1.24
0.37
1.8
1.8
225.2
224.8
pmol/l
0.00
21
160
8
116
0.69
0.37
2.4
1.5
—
—
—
0
0
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
106
982
1.09
0.34
1.9
1.8
1.5
1.4
%
0.16
96
890
19
155
1.23
0.32
1.6
1.5
—
—
—
0
0
13
104
1.25
0.26
1.1
1.1
125.6
117.2
%
0.43
13
95
17
141
1.21
0.26
5.1
2.1
0.8
0.9
nmol/l
0.24
17
121
40
358
1.12
0.26
1.1
1.0
—
—
—
0
0
10
78
1.29
0.24
1.0
1.1
109.2
94.2
%
—
10
73
10
78
1.29
0.24
2.3
1.3
0.6
0.6
nmol/l
—
10
73
122
1161
1.06
0.22
2.9
2.7
0.6
0.7
ug/l
1.59
76
702
0
10
0.00
0.21
0.0
2.5
—
0.4
—
0
10
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
32
290
1.11
0.18
3.1
2.4
42.3
41.4
u/ml
0.02
32
279
13
110
1.18
0.17
1.3
1.3
1.2
4.0
u/ml
—
6
37
41
442
0.92
0.16
1.5
1.5
—
—
—
0
0
30
275
1.09
0.14
1.4
1.3
167.6
242.2
miu/ml
0.56
13
139
12
138
0.87
0.13
2.2
1.8
—
—
—
0
0
20
186
1.08
0.07
1.6
1.7
—
—
—
0
0
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
32
306
1.05
0.05
1.7
1.7
2.6
3.2
mg/l
0.26
24
217
12
110
1.09
0.05
1.0
1.1
—
—
—
0
0
25
241
1.04
0.02
1.8
1.7
—
—
—
0
0
12
113
1.06
0.02
1.3
1.4
16.8
22.4
u/l
—
7
97
30
296
1.01
0.00
1.7
1.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
14.0
—
0
6
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.2
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_SUPERF_MYCOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_SUPERF_MYCOSIS | 1.458 [1.17, 1.82] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.101 |
During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 1804 females with AB1_OTHER_SUPERF_MYCOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_SUPERF_MYCOSIS | 1.789 [1.46, 2.2] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 270 out of 1925 males with AB1_OTHER_SUPERF_MYCOSIS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_SUPERF_MYCOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.135% | 0.398% |
| 5 | 0.8% | 2.169% |
| 10 | 2.085% | 5.0% |
| 15 | 4.018% | 9.478% |
| 20 | 7.086% | 15.894% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_SUPERF_MYCOSIS – Other superficial mycoses
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data